Founded in 2011, Strategic Market Access (SMA) is a market access consultancy focused on value strategy and communication. The company assists its biopharmaceutical clients in defining, articulating, and supporting the value of their products to payers, policymakers, and providers. Their services include developing pricing and reimbursement strategies, creating value communication tools, and conducting health economics and outcomes research to ensure products can achieve successful market entry and sustained access.

Founded in

United Kingdom